On Tuesday, the Advanced Research Projects Agency for Health (ARPA-H) held a day-long gathering related to its ibogaine funding opportunity, dubbed Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better Outcomes in Opioid Use Disorder (ASCENT-IBO, for short).
On Tuesday, the Advanced Research Projects Agency for Health (ARPA-H) held a day-long gathering related to its ibogaine funding opportunity, dubbed Accelerating Safe Clinical Evaluation of Novel Treatments:
Ibogaine for Better Outcomes in Opioid Use Disorder (ASCENT-IBO, for short).
That opportunity is outlined in a Special Notice issued by the agency, with proposals due October […]
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
On Tuesday, the Advanced Research Projects Agency for Health (ARPA-H) held a day-long gathering related to its ibogaine funding opportunity, dubbed Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better Outcomes in Opioid Use Disorder (ASCENT-IBO, for short). That opportunity is outlined in a Special Notice issued by the agency, with proposals due October […]
Open the app view to save this story, compare related coverage, and continue from the same source.